dr. jain on the combination of venetoclax and ibrutinib in cll
Published 6 years ago • 387 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
1:30
dr. jain on pd-1 expression in nivolumab/ibrutinib combination in cll
-
2:12
dr. brander on the safety and efficacy of ibrutinib/venetoclax in cll
-
32:51
part 2 - how do i use btki for cll management? - dr. nitin jain, usa
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
0:15
copy of dr. kaplan on the combination of ibrutinib and venetoclax in mcl
-
1:46
novel agent combinations for cll: ibrutinib, venetoclax, obinutuzumab and zanubrutinib
-
2:45
optimizing the combination of ibrutinib plus venetoclax in cll
-
1:00
dr. jain on the combination of idelalisib and rituximab for older patients with cll
-
2:34
dr. davids on the combination of ibrutinib and obinutuzumab in cll
-
5:13
ash 2019 interview - dr nitin jain and deborah sims - ibrutinib & venetoclax in patients with cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
3:02
combined ibrutinib and venetoclax in patients with treatment-naïve high-risk cll
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
1:28
ibrutinib and venetoclax: a powerful combination in frontline and relapsed cll
-
3:01
ibrutinib venetoclax for cll
-
1:02
combination therapies in cll: ibrutinib and venetoclax
-
1:31
dr. smith on the rationale behind the fixed duration trial for ibrutinib/venetoclax in cll
-
0:43
ideal patient for venetoclax/obinutuzumab combination | dr. jeff sharman | oncology brothers #2023